Immediate Impact

1 by Nobel laureates 3 from Science/Nature 52 standout
Sub-graph 1 of 25

Citing Papers

Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
2022 Standout
Next-generation cancer organoids
2021 Standout
1 intermediate paper

Works of Caroline Clark being referenced

Epidermal growth factor receptor copy number gain (EGFR CNG) and response to gefitinib in esophageal cancer (EC): Results of a biomarker analysis of a phase III trial of gefitinib versus placebo (TRANS-COG).
2014
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases
2002

Author Peers

Author Last Decade Papers Cites
Caroline Clark 205 185 110 251 29 651
Angela Michelucci 268 195 84 213 44 638
Walter Voigt 100 159 142 172 34 820
Joel Mefford 125 273 21 228 34 740
Po‐Han Lin 199 263 74 254 37 755
Raymon Vijzelaar 63 381 46 131 29 634
Tsuyoshi Nakayama 267 300 65 114 49 776
Stephan Buch 123 163 96 122 31 623
Veronika Csöngei 65 192 70 98 29 707
Maria Teresa Landi 167 388 41 259 26 754
Sarah H. Tannehill‐Gregg 244 334 30 295 24 770

All Works

Loading papers...

Rankless by CCL
2026